Dr. LK Medina-Kauwe developed a bioengineered delivery system to treat resistant and metastatic tumors using nano-bioparticles.
By repurposing parts of viruses, growth factors, and nucleic acid-binding proteins, a bioengineered therapeutic delivery vehicle was created and is being evaluated as a cancer-specific molecular missile.
Dr. LK Medina-Kauwe combined the cell-binding, membrane-penetration, and intracellular trafficking functions of pathogen proteins and naturally occurring protein ligands to develop a biologically based tumor-homing platform technology.
This technology is designed to self-assemble with and selectively deliver therapeutic molecules to resistant and metastatic tumors using nano-sized biologically derived particles, or nano-bioparticles (NBPs).
Author's summary: Nano-bioparticles fight cancer with targeted nanotherapy.